Skip to main content
Clinical Trials/IRCT2015011020624N1
IRCT2015011020624N1
Completed
Early Phase 1

Comparison of naloxone & buprenorphine on reversal of Opioid Overdose Syndrome and withdrawal in Methadone – Dependant Patients; An experimental Study

Overview

Phase
Early Phase 1
Intervention
Not specified
Conditions
Methadone Overdose.
Sponsor
Shahid Beheshti University of Medical Sciences
Enrollment
90
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • all opioid\-dependant patients who refer after methadone overdose will be included and randomly assigned into either case (buprenorphine with two different doses) or control (naloxone) group.
  • Exclusion criteria:
  • 1\-Those younger than 12 years of age and older than 100 years will be excluded.
  • 2\- Patients with multiple drug overdoses will be excluded.
  • 3\-Patients who do not respond to the buprenorphien and naloxone doses and are in life\-treathening situation will be intubated and excluded from the study.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials